wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48172134-B926EAB0-49A4-4A8B-8DD1-2553879A3BAE
Q48172134-B926EAB0-49A4-4A8B-8DD1-2553879A3BAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48172134-B926EAB0-49A4-4A8B-8DD1-2553879A3BAE
Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancer.
P2860
Q48172134-B926EAB0-49A4-4A8B-8DD1-2553879A3BAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48172134-B926EAB0-49A4-4A8B-8DD1-2553879A3BAE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dbf8551338b4a0f2517bcb3074a97665bda43020
P2860
A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumors